Journal ArticleOPEN ACCESS

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis

Scientific Reports (2020) 10(1)
DOI: 10.1038/s41598-020-66182-8
14Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

2.5, in whom one (2.5%) had EBR/GZR-induced late ALT elevation. No patients developed hyperbilirubinemia or hepatic decompensation. In conclusion, treatment with EBR/GZR is effective and well-tolerated for East-Asian HCV GT1b patients receiving hemodialysis.

Cite

CITATION STYLE

APA

Liu, C. H., Peng, C. Y., Fang, Y. J., Kao, W. Y., Yang, S. S., Lin, C. K., … Kao, J. H. (2020). Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-66182-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free